Rheumatoid arthritis

Patients anxious about DMARDs and COVID-19 risk

Patients with rheumatic diseases are concerned about their medications increasing the risk of COVID-19 disease, particularly those on combination csDMARDs or a b/tsDMARD, Australian research shows. A survey of 550 patients at the Monash Health Department of Rheumatology Department found that 56% were concerned that their medications would increase their risk of contracting COVID-19, and ...

Already a member?

Login to keep reading.

© 2021 the limbic